AbCellera and Eli Lilly join hunt for coronavirus therapy

Canadian biotech AbCellera has joined forces with Eli Lilly to co-develop antibody products to prevent and treat COVID-19, the disease caused by the novel SARS-Cov-2 coronavirus.

FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidn...

Pharma staff told to work at home as Biogen deals with coron...

The coronavirus has begun to affect day-to-day operations at pharma companies, with Biogen dealing with an outbreak linked to a management meeting at an affected hotel, and others telling s

FDA starts review of Pfizer, Lilly’s non-opioid painkiller

CHMP turns down Lilly’s Emgality for cluster headache

Lilly's Cyramza closer to first-line lung cancer use after O...